(Q37262393)

19 August 2017

1 reference

title

Human embryonic stem cells for cardiomyogenesis (English)

1 reference

human embryonic stem cell

19 August 2017

1 reference

Manhal Habib

1

1 reference

PubMed ID

18775434

19 August 2017

Oren Caspi

series ordinal

2

1 reference

PubMed ID

18775434

19 August 2017

Lior Gepstein

series ordinal

3

1 reference

19 August 2017

30 August 2008

1 reference

Journal of Molecular and Cellular Cardiology

19 August 2017

1 reference

19 August 2017

45

1 reference

19 August 2017

4

1 reference

19 August 2017

462-474

1 reference

Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

7 January 2021

Regenerating the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Cell-based cardiac repair: reflections at the 10-year point

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Stem-cell therapy for cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Myocyte renewal and ventricular remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Establishment in culture of pluripotential cells from mouse embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Embryonic stem cell lines derived from human blastocysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Embryonic stem cell research. The case against...

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Can we develop ethically universal embryonic stem-cell lines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human embryonic stem cell research: ethical and legal issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Embryonic stem cell research. The case for...

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Development. The path to the heart and the road not taken.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Mesp1 at the heart of mesoderm lineage specification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Origins and fates of cardiovascular progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Differentiation pathways in human embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Calcium handling in human embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Endothelial cells derived from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Stem cell differentiation requires a paracrine pathway in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Stable benefit of embryonic stem cell therapy in myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Transgenic enrichment of cardiomyocytes from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Identification and selection of cardiomyocytes during human embryonic stem cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Formation of human myocardium in the rat heart from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human embryonic stem cell transplantation to repair the infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Systems approaches to preventing transplanted cell death in cardiac repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Heart muscle engineering: an update on cardiac muscle replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Engineering vascularized skeletal muscle tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Selection of ventricular-like cardiomyocytes from ES cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Genomic alterations in cultured human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Scalable production of embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Characterization of the expression of MHC proteins in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Tolerance strategies for stem-cell-based therapies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Generation of germline-competent induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Induced pluripotent stem cell lines derived from human somatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.08.008

10.1016/J.YJMCC.2008.08.008

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18775434